What stage does Neo Kuma Ventures invest at?

Neo Kuma Ventures invests at the Pre-Seed, Series A stages.

What is Neo Kuma Ventures's typical check size?

Neo Kuma Ventures typically writes checks of $195K – $1.3M.

What sectors does Neo Kuma Ventures focus on?

Neo Kuma Ventures focuses on Biotech, Digital Health, Healthtech, Mental Health.

Where is Neo Kuma Ventures located?

Neo Kuma Ventures is headquartered in London, GB.

Neo Kuma Ventures

Venture capital

London · Pre-Seed–Series A · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Neo Kuma Ventures

Paths you didn't know you had: your email and LinkedIn already hold routes to the Neo Kuma Ventures team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

The fund believes psychedelic compounds represent a paradigm shift in mental health treatment, with FDA breakthrough designations validating their potential to address root causes of mental illness affecting over 350 million patients globally. Investment focuses on the intersection of expanding clinical evidence, regulatory liberalization, and ecosystem development. The firm targets early-stage, science-driven ventures across compounds, clinic operations, digital therapeutics, and care platforms, leveraging expertise in biotech, pharmaceutical development, and policy advocacy to support founders from inception to scale.

Invests inBiotech Digital Health Healthtech Mental Health Europe Global London

Source: firm website, verified Aug 6, 2026.

Leave your own feedback

Stage

Pre-Seed–Series A

Check

$195K – $1.3M

London, GB

Instruments

Equity

Founded

2021

Tracked investments

Acquisitions

Team · 7 people

from the firm's website & public directories

Clara Burtenshaw· Founder and Investor· Lisbon, Portugalin

A biotech and life sciences investor with over 15 years in venture capital, private equity, operations, and deal execution. Recognized among the most influential women in psychedelics by Business Insider, with education from Oxford University and NYU School of Law.

Sean McLintock· Founder and Advisor· Londonin 𝕏

An entrepreneur and investor with expertise in wealth planning, trade finance, and family office experience. Previously involved with Andela, a high-growth technology company backed by Google Ventures.

Christina Sass· Advisory Board

An executive coach and co-founder and chair of Andela, where she raised over $181M and grew the organization to over 2,000 employees with a $50M run rate within six years. Prior experience includes roles at the MasterCard Foundation and the Clinton Global Initiative.

Fergus Argyle· Advisor

An experienced investor in public and private companies across credit and equity markets with broad expertise in technology, medical devices, pharmaceuticals, and biologics. Career includes senior roles at Blackrock and boutique investment firms in London and Asia.

Lomax Ward· Advisory Board

Co-founder and general partner at Outsized Ventures focused on human health. Previously a healthcare and life sciences investor at White Cloud and a corporate lawyer at Slaughter and May.

Peter Crane· Advisor, Chemical biology

A venture partner with healthcare investment and pharmaceutical expertise, holding a DPhil in Chemical Biology from Oxford University and a master's degree in chemistry from Warwick University.

Willem Hendrik Gispen· Advisor, Neuropharmacology

A medical biologist and neuroscientist holding distinguished academic positions including Head of the Department of Molecular Neurobiology and Rector Magnificus at Utrecht University, and Director of the Rudolf Magnus Institute for Neuroscience.

What they invest in

from 3 of 3 portfolio companies

Digital Health ×3Mental Health ×2Wellness & Fitness ×2Healthtech ×1HR Tech ×1Medical Devices ×1

HQs:United Kingdom×1

Investments · 3 tracked

founders shown can be your intro path

By year:2023 · 1 2021 · 23 dated

Journey Clinicaljourneyclinical.com in 𝕏Sep 2021 · $3M

Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.

Digital HealthMedical DevicesMental Health

Jonathan Sabbagh(Founder)in Myriam Barthes(Founder)in

Co-investorsAble Partners AlleyCorp Coalition Operators Fifty Years FJ Labs Gaingels +9 more

Syndi Healthsyndi.health inFeb 2023 · $2MAcquired

Syndi (HealthKey) operates a platform that gives organisations access to around 75 vetted healthcare providers, letting employers and insurers offer employees and customers services like therapy, physiotherapy, nutrition and at-home testing.

Digital HealthHealthtechHR TechWellness & FitnessLondon, GB

Benjamin Lakey(CEO)in Jorge Alexander(Founding CTO)in

Co-investorsEntrepreneur First Plug and Play Ventures Founders Factory Innovate UK REMUS Capital

Wavepathswavepaths.com in 𝕏Oct 2021 · $4.5M

Wavepaths develops adaptive therapeutic music designed to support mental health and wellness practitioners in their sessions.

Digital HealthMental HealthWellness & Fitness

Mendel Kaelen(Founder & CEO)in

Co-investorsMITON Reflex Capital Tabula Rasa Ventures Empath Ventures LIONHEART VENTURES Palo Santo VC

Frequently asked questions

What stage does Neo Kuma Ventures invest at?: Neo Kuma Ventures invests at the Pre-Seed, Series A stages.
What is Neo Kuma Ventures's typical check size?: Neo Kuma Ventures typically writes checks of $195K – $1.3M.
What sectors does Neo Kuma Ventures focus on?: Neo Kuma Ventures focuses on Biotech, Digital Health, Healthtech, Mental Health.
Where is Neo Kuma Ventures located?: Neo Kuma Ventures is headquartered in London, GB.

Media · Podcasts & interviews

featuring the team

Advancements in psychedelic therapy - Expert Talk with Sean McLintock , Neo Kuma Ventures

Kalkine Media · Sean McLintock

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Menlo Ventures

Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.

$1M – $20M

F-Prime Capital

F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.

$3M – $10M

MedMountain Ventures

MedMountain Ventures (MMV) is a physician-led venture capital firm founded by board-certified physicians that invests early in transformative healthcare companies aiming to improve patient outcomes and reform care delivery.

$500K – $5M

Mystic Ventures

Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.